Exagen Inc. (XGN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 17, 2021, reports on the results of Exagen Inc.'s 2021 Annual Meeting of Stockholders. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol XGN.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal 1 (Election of Directors): Stockholders elected two Class II directors for a three-year term expiring in 2024.
- Frank Stokes: 11,567,382 votes For; 1,740 votes Withheld; 2,136,654 Broker Non-Votes.
- James L.L. Tullis: 10,730,656 votes For; 838,466 votes Withheld; 2,136,654 Broker Non-Votes.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
- Votes For: 13,666,304
- Votes Against: 0
- Abstentions: 39,472
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- James L.L. Tullis received a significant number of withheld votes (838,466) compared to Frank Stokes (1,740), indicating potential shareholder dissatisfaction or specific concerns regarding that director.
- The ratification of BDO USA, LLP as the independent auditor passed with overwhelming support.
- The filing confirms the company's status as an emerging growth company.